Phenyl methoxycarbamate → HCID 86629524, 화합물
반응식
[C:1]([O:5][C:6](=[O:26])[NH:7][CH2:8][CH2:9][C@H:10]([N:12]1[CH2:17][CH2:16][CH:15]([NH:18][CH2:19][CH:20]2[CH2:25][CH2:24][CH2:23][CH2:22][CH2:21]2)[CH2:14][CH2:13]1)[CH3:11])([CH3:4])([CH3:3])[CH3:2].C1([O:33][C:34](=O)[NH:35][O:36][CH3:37])C=CC=CC=1>C1COCC1>[C:1]([O:5][C:6](=[O:26])[NH:7][CH2:8][CH2:9][C@H:10]([N:12]1[CH2:17][CH2:16][CH:15]([N:18]([CH2:19][CH:20]2[CH2:25][CH2:24][CH2:23][CH2:22][CH2:21]2)[C:34]([NH:35][O:36][CH3:37])=[O:33])[CH2:14][CH2:13]1)[CH3:11])([CH3:2])([CH3:3])[CH3:4]참가 물질
4
반응 조건
- 온도
- 60 °C
실험 절차
To a solution of {(R)-3-[4-(cyclohexylmethyl-amino)-piperidin-1-yl]-butyl}-carbamic acid tert-butyl ester (174 mg, 0.47 mmol) in THF (5 ml) was added methoxy-carbamic acid phenyl ester (94.7 mg, 0.56 mmol). The mixture was stirred at 60° C. for 3 d then concentrated in vacuo. The crude product was purified by flash chromatography (CH2Cl2, 7% MeOH, 1% NH4OH) to afford {(R)-3-[4-(1-cyclohexylmethyl-3-methoxy-ureido)-piperidin-1-yl]-butyl}-carbamic acid tert-butyl ester (105 mg, 50%) as a yellow oil.